173 related articles for article (PubMed ID: 21568876)
1. Design, synthesis of novel quinazolone alkaloids derivatives as potential antitumor agents.
Zheng Y; Sun M; Liu Y; Li M; Ji M
Med Chem; 2011 Jul; 7(4):295-300. PubMed ID: 21568876
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of a quinazolinone natural product-templated library with cytotoxic activity.
Liu JF; Kaselj M; Isome Y; Ye P; Sargent K; Sprague K; Cherrak D; Wilson CJ; Si Y; Yohannes D; Ng SC
J Comb Chem; 2006; 8(1):7-10. PubMed ID: 16398546
[No Abstract] [Full Text] [Related]
3. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and assessment of new series of quinazolinone derivatives as EGFR inhibitors along with their cytotoxic evaluation against MCF7 and A549 cancer cell lines.
Aziz MW; Kamal AM; Mohamed KO; Elgendy AA
Bioorg Med Chem Lett; 2021 Jun; 41():127987. PubMed ID: 33771586
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of novel 3-substituted imidazo[1,2-a]pyridine and quinazolin-4(3H)-one derivatives as PI3Kα inhibitors.
Fan YH; Li W; Liu DD; Bai MX; Song HR; Xu YN; Lee S; Zhou ZP; Wang J; Ding HW
Eur J Med Chem; 2017 Oct; 139():95-106. PubMed ID: 28800461
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and
Le Y; Gan Y; Fu Y; Liu J; Li W; Zou X; Zhou Z; Wang Z; Ouyang G; Yan L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):555-564. PubMed ID: 31967481
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers.
Wang C; Xu S; Peng L; Zhang B; Zhang H; Hu Y; Zheng P; Zhu W
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):203-217. PubMed ID: 30835140
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of some novel quinazolinone derivatives as potent apoptotic inducers.
Nowar RM; A Osman EE; Abou-Seri SM; El Moghazy SM; Abou El Ella DA
Future Med Chem; 2018 May; 10(10):1191-1205. PubMed ID: 29749767
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors.
El-Adl K; El-Helby AA; Ayyad RR; Mahdy HA; Khalifa MM; Elnagar HA; Mehany ABM; Metwaly AM; Elhendawy MA; Radwan MM; ElSohly MA; Eissa IH
Bioorg Med Chem; 2021 Jan; 29():115872. PubMed ID: 33214036
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4(3H)quinazolinone analogues.
Al-Suwaidan IA; Abdel-Aziz AA; Shawer TZ; Ayyad RR; Alanazi AM; El-Morsy AM; Mohamed MA; Abdel-Aziz NI; El-Sayed MA; El-Azab AS
J Enzyme Inhib Med Chem; 2016; 31(1):78-89. PubMed ID: 25815668
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of 1,4-substituted 1H-1,2,3-triazolo-quinazolin-4(3H)-ones by Huisgen 1,3-dipolar cycloaddition with PI3Kγ isoform selective activity.
Srinivas M; Singh Pathania A; Mahajan P; Verma PK; Chobe SS; Malik FA; Nargotra A; Vishwakarma RA; Sawant SD
Bioorg Med Chem Lett; 2018 Apr; 28(6):1005-1010. PubMed ID: 29486969
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of alkylphosphocholine-gefitinib conjugates as multitarget anticancer agents.
Alam MM; Hassan AHE; Kwon YH; Lee HJ; Kim NY; Min KH; Lee SY; Kim DH; Lee YS
Arch Pharm Res; 2018 Jan; 41(1):35-45. PubMed ID: 29094267
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2.
Lu L; Zhao TT; Liu TB; Sun WX; Xu C; Li DD; Zhu HL
Chem Pharm Bull (Tokyo); 2016 Nov; 64(11):1570-1575. PubMed ID: 27568484
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Antitumor Activity of Novel Quinazoline Derivatives.
Wang L; Li P; Li B; Wang Y; Li J; Song L
Molecules; 2017 Sep; 22(10):. PubMed ID: 28956845
[TBL] [Abstract][Full Text] [Related]
16. Parallel solution phase synthesis of 3,6,7-4(3H)-quinazolinones and evaluation of their antitumor activities against human cancer.
Wu H; Xie X; Liu G
J Comb Chem; 2010 May; 12(3):346-55. PubMed ID: 20196566
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds.
Mohamed MA; Ayyad RR; Shawer TZ; Abdel-Aziz AA; El-Azab AS
Eur J Med Chem; 2016 Apr; 112():106-113. PubMed ID: 26890117
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues.
El-Azab AS; Abdel-Aziz AA; Ghabbour HA; Al-Gendy MA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1229-1239. PubMed ID: 28948843
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction.
Wang YQ; Huang ZL; Chen SB; Wang CX; Shan C; Yin QK; Ou TM; Li D; Gu LQ; Tan JH; Huang ZS
J Med Chem; 2017 Aug; 60(16):6924-6941. PubMed ID: 28714689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
